ConductScience.org, home

Paper1259639

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer.

Katzman R. Arch Neurol, 1976. Cited by 540 papers, by iCite.

Cite this record

ConductScience Library. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Papers, record 1259639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1259639

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Editorial: The prevalence and malignancy of Alzheimer disease. A major killer.
PubMed
Journal
Arch Neurol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
540
iCite
Relative citation ratio, by iCite
14.6
iCite
Revised in PubMed
2019-07-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Katzman RR

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
DementiaMajor topic
Humans
United States

Cited by124

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 540 citations.

PMIDTitleJournalYearIn PapersSource
42921272Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies.MedComm (2020)2026https://conductscience.org/library/papers/42921272PubMed
42805939Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact.Alzheimers Dement2026https://conductscience.org/library/papers/42805939PubMed
42274769Alzheimer's disease-cancer research (inception to 2025): trends, themes, translational pathways, and insights from highly cited studies.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42274769PubMed
42186792Behavior of neural networks in culture suggest that sporadic and genetic forms of Alzheimer's disease may not be equivalent.Alzheimers Dement2026https://conductscience.org/library/papers/42186792PubMed
41702711Defining Alzheimer's disease: stipulations and the ethics of diagnostic change.J Neurol Neurosurg Psychiatry2026https://conductscience.org/library/papers/41702711PubMed
41227148Alzheimer Syndrome or Age-Related Dementia-History, Therapy and Prevention.J Clin Med2025https://conductscience.org/library/papers/41227148PubMed
41200107Developing and optimizing a biocompatible tauopathy model using extracellular vesicle-mediated gene delivery.Front Med (Lausanne)2025https://conductscience.org/library/papers/41200107PubMed
41085158Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers.Alzheimers Dement2025https://conductscience.org/library/papers/41085158PubMed
41056420Placing public health onto the Alzheimer's disease and related dementias public policy platform.Gerontologist2025https://conductscience.org/library/papers/41056420PubMed
40864225Donepezil and Memantine Derivatives for Dual-Function and Prodrug Applications in Alzheimer's Disease.ACS Chem Neurosci2025https://conductscience.org/library/papers/40864225PubMed
40772536The first 25 years of the Northwestern University SuperAging Program.Alzheimers Dement2025https://conductscience.org/library/papers/40772536PubMed
40011173Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics.J Prev Alzheimers Dis2025https://conductscience.org/library/papers/40011173PubMed
39529357Alzheimer's disease: part 2 - the present.Arq Neuropsiquiatr2024https://conductscience.org/library/papers/39529357PubMed
39473810Characteristics of Alzheimer's Disease and Mild Cognitive Impairment Influenced by the Time of Onset.Dement Geriatr Cogn Dis Extra2024https://conductscience.org/library/papers/39473810PubMed
39295642In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more.Front Aging Neurosci2024https://conductscience.org/library/papers/39295642PubMed
38863570What is "biological Alzheimer's disease"?Dement Neuropsychol2024https://conductscience.org/library/papers/38863570PubMed
38641654The advent of Alzheimer treatments will change the trajectory of human aging.Nat Aging2024https://conductscience.org/library/papers/38641654PubMed
38618742What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries.Eur J Neurol2024https://conductscience.org/library/papers/38618742PubMed
38482142Atypical clinical variants of Alzheimer's disease: are they really atypical?Front Neurosci2024https://conductscience.org/library/papers/38482142PubMed
38256670Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History.J Clin Med2024https://conductscience.org/library/papers/38256670PubMed

See all 124 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1259639

GET https://conductscience.org/api/papers/v1/1259639/cited_by?page=2